Psoriatic arthritis enthesitis — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Escalate to a biologic pathway after eligibility assessment
Explanation lettering: D = shown as B · E = shown as C · C = shown as D · B = shown as E
Escalate to a biologic pathway after eligibility assessment is best because persistent active enthesitis despite NSAIDs and physiotherapy can warrant escalation to approved biologic therapy in PsA. B is less suitable because intratendinous steroid injection risks tendon rupture; C is less suitable because long-term antibiotics are not PsA treatment; D is less suitable because allopurinol treats gout; E is less suitable because bisphosphonates treat osteoporosis or Paget disease rather than enthesitis. Clinical pearl: enthesitis is a disease domain that may justify biologic escalation even when synovitis count is low.
Reference: BSR psoriatic arthritis biologic guideline 2022; NICE NG65